Influences of the recombinant artificial cell adhesive proteins on the behavior of human umbilical vein endothelial cells in serum-free culture

Biologicals

Volumn 35, Issue 4, 2007, Pages 247-257

  Ishii Watabe, Akiko ^a   Kanayasu Toyoda, Toshie ^a   Suzuki, Takuo ^a   Kobayashi, Tetsu ^a   Yamaguchi, Teruhide ^a   Kawanishi, Toru ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Cell adhesive protein; Endothelial cells; Fibronectin; Recombinant protein

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL ADHESION MOLECULE; FIBRONECTIN; FOCAL ADHESION KINASE; INTEGRIN; PROSTACYCLIN; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; VASCULOTROPIN;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN COS1; CELL THERAPY; CHO CELL; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; PRIORITY JOURNAL; SAFETY; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VERO CELL;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL ADHESION; CELL ADHESION MOLECULES; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL CELLS; EPOPROSTENOL; FIBRINOLYTIC AGENTS; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; RECOMBINANT PROTEINS; THROMBIN;

ANIMALIA;

EID: 35248822760     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2006.12.002     Document Type: Article

References (52)

1. Wollert K.C., and Drexler H. Cell-based therapy for heart failure. Curr Opin Cardiol 21 (2006) 234-239
2. Zavos P.M. Stem cells and cellular therapy: potential treatment for cardiovascular diseases. Int J Cardiol 107 (2006) 1-6
3. Fazel S., Tang G.H., Angoulvant D., Cimini M., Weisel R.D., Li R.K., et al. Current status of cellular therapy for ischemic heart disease. Ann Thorac Surg 79 (2005) S2238-S2247
4. http://www.fda.gov/cber/gdlns/somgene.pdf
5. http://www.fda.gov/cber/gdlns/cmcsomcell.pdf
6. http://www.emea.eu.int/pdfs/human/cpwp/32377405en.pdf
7. http://www.fda.gov/cber/rules/suitdonor.pdf
8. Lee J.B., Lee J.E., Park J.H., Kim S.J., Kim M.K., Roh S.I., et al. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod 72 (2005) 42-49
9. Ogawa K., Matsui H., Ohtsuka S., and Niwa H. A novel mechanism for regulating clonal propagation of mouse ES cells. Genes Cells 9 (2004) 471-477
10. Asher D.M. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies. Dev Biol Stand 99 (1999) 41-44
11. Asher D.M. The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics. Dev Biol Stand 100 (1999) 103-118
12. Cobo F., Stacey G.N., Hunt C., Cabrera C., Nieto A., Montes R., et al. Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol 68 (2005) 456-466
13. Cobo F., Talavera P., and Concha A. Diagnostic approaches for viruses and prions in stem cell banks. Virology 347 (2006) 1-10
14. Kornblihtt A.R., Umezawa K., Vibe-Pedersen K., and Baralle F.E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J 4 (1985) 1755-1759
15. Umezawa K., Kornblihtt A.R., and Baralle F.E. Isolation and characterization of cDNA clones for human liver fibronectin. FEBS Lett 186 (1985) 31-34
16. Pierschbacher M.D., and Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309 (1984) 30-33
17. Ruoslahti E., and Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 238 (1987) 491-497
18. Bourdoulous S., Orend G., MacKenna D.A., Pasqualini R., and Ruoslahti E. Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J Cell Biol 143 (1998) 267-276
19. Frisch S.M., and Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9 (1997) 701-706
20. Heslot H. Artificial fibrous proteins: a review. Biochimie 80 (1998) 19-31
21. Cappello J. Genetically Engineered Protein Polymers. In: Domb A.J., Kost J., and Wiseman D. (Eds). Handbook of Biodegradable Polymers (1997), Harwood Academic Publishers, Amsterdam 387-416
22. Hosseinkhani H., and Tabata Y. PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin. J Control Release 97 (2004) 157-171
23. Hanenberg H., Xiao X.L., Dilloo D., Hashino K., Kato I., and Williams D.A. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2 (1996) 876-882
24. http://home.kimo.com.tw/biotaichchen/Attachin/into.html
25. http://home.kimo.com.tw/biotaichchen/Attachin/qa.html
26. Gorfien S., Spector A., DeLuca D., and Weiss S. Growth and physiological functions of vascular endothelial cells in a new serum-free medium (SFM). Exp Cell Res 206 (1993) 291-301
27. Zaric J., and Ruegg C. Integrin-mediated adhesion and soluble ligand binding stabilize COX-2 protein levels in endothelial cells by inducing expression and preventing degradation. J Biol Chem 280 (2005) 1077-1085
28. Ilic D., Kovacic B., Johkura K., Schlaepfer D.D., Tomasevic N., Han Q., et al. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J Cell Sci 117 (2004) 177-187
29. Almeida E.A., Ilic D., Han Q., Hauck C.R., Jin F., Kawakatsu H., et al. Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J Cell Biol 149 (2000) 741-754
30. Schlaepfer D.D., Broome M.A., and Hunter T. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Mol Cell Biol 17 (1997) 1702-1713
31. Ruest P.J., Roy S., Shi E., Mernaugh R.L., and Hanks S.K. Phosphospecific antibodies reveal focal adhesion kinase activation loop phosphorylation in nascent and mature focal adhesions and requirement for the autophosphorylation site. Cell Growth Differ 11 (2000) 41-48
32. Fuchs S., Motta A., Migliaresi C., and Kirkpatrick C.J. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 27 (2006) 5399-5408
33. Jain R.K., Au P., Tam J., Duda D.G., and Fukumura D. Engineering vascularized tissue. Nat Biotechnol 23 (2005) 821-823
34. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23 (2005) 879-884
35. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., and Jain R.K. Tissue engineering: creation of long-lasting blood vessels. Nature 428 (2004) 138-139
36. Meinhart J.G., Schense J.C., Schima H., Gorlitzer M., Hubbell J.A., Deutsch M., et al. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng 11 (2005) 887-895
37. Julkunen I., Hautanen A., and Keski-Oja J. Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40 (1983) 876-881
38. Torre D., Pugliese A., Ferrario G., Marietti G., Forno B., and Zeroli C. Interaction of human plasma fibronectin with viral proteins of human immunodeficiency virus. FEMS Immunol Med Microbiol 8 (1994) 127-131
39. Merx M.W., Zernecke A., Liehn E.A., Schuh A., Skobel E., Butzbach B., et al. Transplantation of human umbilical vein endothelial cells improves left ventricular function in a rat model of myocardial infarction. Basic Res Cardiol 100 (2005) 208-216
40. Fuchs S., Hermanns M.I., and Kirkpatrick C.J. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res 326 (2006) 79-92
41. Cai H., Gehrig P., Scott T.M., Zimmermann R., Schlapbach R., and Zisch A.H. MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress. Biochem Biophys Res Commun 350 (2006) 364-369
42. Sharpe III E.E., Teleron A.A., Li B., Price J., Sands M.S., Alford K., et al. The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells. Am J Pathol 168 (2006) 1710-1721
43. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93 (2003) 1023-1025
44. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
45. Smadja D.M., Bieche I., Uzan G., Bompais H., Muller L., Boisson-Vidal C., et al. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 25 (2005) 2321-2327
46. Eggermann J., Kliche S., Jarmy G., Hoffmann K., Mayr-Beyrle U., Debatin K.M., et al. Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58 (2003) 478-486
47. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 288-293
48. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
49. Ott I., Keller U., Knoedler M., Gotze K.S., Doss K., Fischer P., et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 19 (2005) 992-994
50. Choi J.H., Hur J., Yoon C.H., Kim J.H., Lee C.S., Youn S.W., et al. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J Biol Chem 279 (2004) 49430-49438
51. Martin M.J., Muotri A., Gage F., and Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11 (2005) 228-232
52. http://www.sanyo-chemical.co.jp/product/pronectin/eng/prodspec.htm